|
27.03.2023 11:34:03
|
EQS-Adhoc: Vitruvia Medical AG: auhtorised capital increase
|
EQS-Ad-hoc: VITRUVIA MEDICAL AG / Key word(s): Capital Increase Ad Hoc Announcement Anglikon, 27 March 2023: Vitruvia Medical AG has carried out an authorised capital increase as of today. Receivables in the amount of CHF 1'680'817.50 were offset, for which 672'327 registered shares at CHF 1.00 each were issued. The issue price was CHF 2.50 per registered share. The share capital of Vitruvia Medical AG now amounts to CHF 2,511,578.00. Vitruvia Medical AG Markus A. Bertschin Chairman of the Board of Directors
27-March-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Vitruvia Medical AG |
| Kesselackerstr. 18 | |
| 5611 Anglikon | |
| Switzerland | |
| Phone: | +41 44 915 33 78 |
| E-mail: | kontakt@vitruvia-med.com |
| Internet: | www.vitruvia-med.com |
| ISIN: | CH0461931419 |
| WKN: | A2PDWF |
| Listed: | Regulated Unofficial Market in Munich |
| EQS News ID: | 1593069 |
| End of Announcement | EQS News Service |
|
|
1593069 27-March-2023 CET/CEST
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu VITRUVIA MEDICAL AGmehr Nachrichten
|
25.07.24 |
EQS-Adhoc: Vitruvia Medical AG: Halbjahresergbnis per 30. Juni 2024 (EQS Group) | |
|
25.07.24 |
EQS-Adhoc: Vitruvia Medical AG: Half yearly results as per June 30th, 2024 (EQS Group) |
Analysen zu VITRUVIA MEDICAL AGmehr Analysen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.